280 related articles for article (PubMed ID: 10831483)
1. Placebo-controlled trial of sertraline in the treatment of binge eating disorder.
McElroy SL; Casuto LS; Nelson EB; Lake KA; Soutullo CA; Keck PE; Hudson JI
Am J Psychiatry; 2000 Jun; 157(6):1004-6. PubMed ID: 10831483
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome.
O'Reardon JP; Allison KC; Martino NS; Lundgren JD; Heo M; Stunkard AJ
Am J Psychiatry; 2006 May; 163(5):893-8. PubMed ID: 16648332
[TBL] [Abstract][Full Text] [Related]
3. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
[TBL] [Abstract][Full Text] [Related]
4. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.
Hudson JI; McElroy SL; Raymond NC; Crow S; Keck PE; Carter WP; Mitchell JE; Strakowski SM; Pope HG; Coleman BS; Jonas JM
Am J Psychiatry; 1998 Dec; 155(12):1756-62. PubMed ID: 9842788
[TBL] [Abstract][Full Text] [Related]
5. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.
McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE
J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982
[TBL] [Abstract][Full Text] [Related]
6. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.
Davidson JR; Rothbaum BO; van der Kolk BA; Sikes CR; Farfel GM
Arch Gen Psychiatry; 2001 May; 58(5):485-92. PubMed ID: 11343529
[TBL] [Abstract][Full Text] [Related]
7. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
8. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
[TBL] [Abstract][Full Text] [Related]
9. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
Pollack MH; Rapaport MH; Clary CM; Mardekian J; Wolkow R
J Clin Psychiatry; 2000 Dec; 61(12):922-7. PubMed ID: 11206597
[TBL] [Abstract][Full Text] [Related]
10. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
[TBL] [Abstract][Full Text] [Related]
11. Sertraline in the treatment of panic disorder: a double-blind multicenter trial.
Pohl RB; Wolkow RM; Clary CM
Am J Psychiatry; 1998 Sep; 155(9):1189-95. PubMed ID: 9734541
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sertraline in a 12-week trial for generalized anxiety disorder.
Allgulander C; Dahl AA; Austin C; Morris PL; Sogaard JA; Fayyad R; Kutcher SP; Clary CM
Am J Psychiatry; 2004 Sep; 161(9):1642-9. PubMed ID: 15337655
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial.
Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B
Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan.
Kamijima K; Kuboki T; Kumano H; Burt T; Cohen G; Arano I; Hamasaki T
Int Clin Psychopharmacol; 2005 Sep; 20(5):265-73. PubMed ID: 16096517
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Lydiard RB; Stahl SM; Hertzman M; Harrison WM
J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
Leombruni P; PierĂ² A; Lavagnino L; Brustolin A; Campisi S; Fassino S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1599-605. PubMed ID: 18598735
[TBL] [Abstract][Full Text] [Related]
17. Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.
Londborg PD; Hegel MT; Goldstein S; Goldstein D; Himmelhoch JM; Maddock R; Patterson WM; Rausch J; Farfel GM
J Clin Psychiatry; 2001 May; 62(5):325-31. PubMed ID: 11411812
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.
Arnold LM; McElroy SL; Hudson JI; Welge JA; Bennett AJ; Keck PE
J Clin Psychiatry; 2002 Nov; 63(11):1028-33. PubMed ID: 12444817
[TBL] [Abstract][Full Text] [Related]
20. Sertraline for social phobia: a double-blind, placebo-controlled crossover study.
Katzelnick DJ; Kobak KA; Greist JH; Jefferson JW; Mantle JM; Serlin RC
Am J Psychiatry; 1995 Sep; 152(9):1368-71. PubMed ID: 7653696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]